The Food and Drug Administration released data showing that Moderna’s COVID-19 vaccine is safe and effective.

The FDA’s review, which was published on Tuesday, confirmed Moderna’s previous assessment that its vaccine had an efficacy rate of 94.1% in a trial of 30,000 people. It noted that potential side effects of the vaccine include fever, headache, and fatigue but added that those unintended effects were not dangerous.

Recommended Stories

Pfizer submits data on COVID-19 vaccine for children ages 5-11 to FDA

BioNTech co-founder says vaccines will return life to normal by next winter

Vaccine experts question fourth shot as companies seek expanded authorization